Top Downloaded Papers in 2024
The most downloaded papers in BioDrugs in 2024.
- Submission status
- Open
- Submission deadline
- Ongoing
Collections and calls for papers
Top-Cited Papers Published in 2021-2022
The top cited papers that were published in 2021-2022, contributing to the 2023 Impact Factor (source: Clarivate Web of Science, July 2024)
- Submission status
- Open
- Submission deadline
- Ongoing
Gene Therapy
A selection of recent articles on gene therapy. Also see the separate collection for CAR T cell therapy.
- Submission status
- Open
- Submission deadline
- Ongoing
Vaccines for Infectious Diseases
Recent papers on vaccines for infectious diseases
- Submission status
- Open
- Submission deadline
- Ongoing
COVID-19/SARS-CoV-2
A collection of recent articles related to COVID-19/SARS-CoV-2
- Submission status
- Open
- Submission deadline
- Ongoing
Biologics for Immune-Mediated Inflammatory Diseases
A collection of recent manuscripts on biologic therapies for immune-mediated inflammatory diseases (e.g. dermatologic, rheumatologic, respiratory, and gastroenterological).
- Submission status
- Open
- Submission deadline
- Ongoing
Immune Checkpoint Inhibitors in Oncology
A collection of recent articles on immune checkpoint inhibitors for cancer therapy.
- Submission status
- Open
- Submission deadline
- Ongoing
CAR T cells
A collection of recent articles on chimeric antigen receptor (CAR) T cells
- Submission status
- Open
- Submission deadline
- Ongoing
Biosimilar Studies
A collection of recent original research articles on biosimilars
- Submission status
- Open
- Submission deadline
- Ongoing
Biosimilars: Opinions, Reviews and Systematic Reviews
A collection of recent opinions, reviews and systematic reviews on biosimilars
- Submission status
- Open
- Submission deadline
- Ongoing